Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
24.54
+0.42 (1.74%)
At close: Jul 7, 2025, 4:00 PM
23.66
-0.88 (-3.59%)
After-hours: Jul 7, 2025, 6:09 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $275.29 million as of July 7, 2025.
Market Cap
275.29M
Enterprise Value
212.82M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.54
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $275.29M, an increase of 91.21%. That is a compound annual growth rate of 220.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 275.29M | 104.44% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |